![Emma Fisher - Enhertu](https://metupuk.org.uk/wp-content/uploads/2022/12/Emma-enhertu-scaled.jpg)
METUPUK are delighted for the approval of Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received one or more prior anti-HER2 based therapies approved for use through the Cancer Drugs Fund in NHS in England.